Compound Tag
PCSK9
2 research articles in this compound library
Compound Index
IGF-18Hexarelin5Selank4GHRP-24NMN / NR / NAD+ Precursors4BPC-1573TB-5003Ipamorelin3CJC-1295 (DAC)3CJC-1295 / Ipamorelin3CJC-1295 No DAC3Sermorelin3MK-6773Semaglutide3Tirzepatide3Retatrutide3AOD-96043GHK-Cu3Epitalon3Semax3NAD+3PT-1413Melanotan II3Thymosin Alpha-13LL-373MOTS-c3SS-31 (Elamipretide)3Tesamorelin3DSIP3Kisspeptin3
Research Fundamentals8 min read
PCSK9 and Peptides: Emerging Cardiovascular Research Targets
PCSK9 proprotein subtilisin kexin type 9 LDL receptor degradation mechanism, monoclonal antibody and siRNA therapeutic inhibition, peptide-based PCSK9 inhibitor research, standard rodent CV models, and the connection to GLP-1 agonist cardiovascular endpoint design.
May 29, 2026Read
Research Fundamentals10 min read
GLP-1 Agonists for Cardiovascular Research: What the SELECT and LEADER Trials Tell Us
An in-depth analysis of the major cardiovascular outcome trials for GLP-1 receptor agonists — LEADER, SUSTAIN-6, SELECT, SURPASS-CVOT — and what the mechanistic data means for preclinical cardiac and vascular research design.
May 29, 2026Read